Topical ofloxacin treatment of otorrhea in children with tympanostomy tubes

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 5, 1999, Pages 537-545

  Dohar, Joseph E ^a   Garner, Eric T ^b   Nielsen, Richard W ^c   Biel, Merril A ^d   Seidlin, Mindell ^e  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b ENT Associates   (United States)

^c Surgical Services   (United States)

^d Minneapolis Ear Nose Throat Clin R   (United States)

^e Daiichi Pharmaceutical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN;

ARTICLE; BACTERIUM ISOLATE; CHILD; CLINICAL TRIAL; COUGHING; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HALITOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OTALGIA; OTORRHEA; PARESTHESIA; RASH; RHINITIS; TASTE DISORDER; TINNITUS; TOPICAL DRUG ADMINISTRATION; TYMPANOSTOMY TUBE; VOMITING;

EID: 0032953967     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.5.537     Document Type: Article

References (19)

1. Nelson JD. Chronic suppurative otitis media. Pediatr Infect Dis J. 1988;7:446-448.
2. Force RW, Hart MC, Plummer SA, et al. Topical ciprofloxacin for otorrhea after tympanostomy tube placement. Arch Otolaryngol Head Neck Surg. 1995;121: 880-884.
3. Cantor RM. Otitis externa and otitis media: a new look at old problems. Emerg Med Clin North Am. 1995;13:445-455.
4. Dohar JE, Kenna MA, Wadowsky RM. Therapeutic implications in the treatment of aural Pseudomonas infections based on in vitro susceptibility patterns. Arch Otolaryngol Head Neck Surg. 1995;121:1022-1025.
5. Supiyaphun P, Chochaipanichnon L, Tonsakulrungruang K, et al. The treatment of chronic suppurative otitis media and otitis extema with 0.3 percent ofloxacin otic solution: a clinico-microbiologic study. J Med Assoc Thai. 1995;78:18-21.
6. McCracken GH. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J. 1995;14:424-428.
7. Leibovitz E, Raiz S, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J. 1995;14:463-469.
8. Rodriguez WJ, Schwartz RH, Thorne MM. Increasing incidence of penicillin-and ampicillin-resistant middle ear pathogens. Pediatr Infect Dis J. 1995;14:1075-1078.
9. Barlow DW, Duckert LG, Krieg CS, Gates GA. Ototoxicity of topical otomicrobial agents. Acta Otolaryngol (Stockh). 1995;115:231-235.
10. Monsell EM, Cass SP, Rybak LP. Therapeutic use of aminoglycosides in Meniere's disease. Otolaryngol Clin North Am. 1993;26:737-746.
11. Ohyama M, Furuta S, Ueno K, et al. Ofloxacin otic solution in patients with otitis media. Arch Otolaryngol Head Neck Surg. 1999;125:337-340.
12. Cortisporin Otic Solution and Cortisporin Otic Suspension: Material Safety Data Sheet. Bristol, Tenn: Monarch Pharmaceuticals Inc; 1998.
13. Langford JH, Benrimoj SI. Clinical rationale for topical antimicrobial preparations. J Antimicrob Chemother. 1996;37:399-402.
14. Dohar JE, Kenna MA, Wadowsky RM. In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics. Am J Otol. 1996;17:207-209.
15. Schneider ML. Bacteriology of otorrhea from tympanostomy tubes. Arch Otolaryngol Head Neck Surg. 1989;115:1225-1225.
16. Brook I, Yocum P, Shah K. Aerobic and anaerobic bacteriology of otorrhea associated with tympanostomy tubes in children. Acta Otolaryngol (Stockh). 1998; 118:206-210.
17. Kenna MA, Bluestone CD. Microbiology of chronic suppurative otitis media in children. Pediatr Infect Dis. 1986;5:223-225.
18. Hui Y, Park A, Crysdale WS, et al. Ototoxicity from ototopical aminoglycosides. J Otolaryngol. 1997;26:53-56.
19. Wong DLH, Rutka JA. Do aminoglycoside otic preparations cause Ototoxicity in the presence of tympanic membrane perforations? Otolaryngol Head Neck Surg. 1997;116:404-410.